In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K |
Revenues: |
North America | | | 10.2 | 47.0 | 49.8 | 58.2 | 75.4 | 64.4 |
Other Countries | | | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | 0.0 |
Europe | | | | | 3.5 | 12.5 | 10.6 | 11.4 |
Asia | | | | 11.8 | 12.3 | 4.3 | 2.7 | 4.4 |
Other | | | 11.8 | 22.4 | 41.0 | 17.4 | 0.9 | 18.4 |
Total revenues [+] | 12.8 | 11.4 | 22.0 | 81.2 | 106.5 | 92.6 | 89.9 | 98.7 |
Products | 12.8 | 11.4 | | | | | | |
Revenue growth [+] | 12.9% | -48.4% | -72.9% | -23.8% | 14.9% | 3.0% | -8.9% | 26.0% |
North America | | | -78.3% | -5.6% | -14.5% | -22.9% | 17.2% | 46.2% |
Other Countries | | | 77.4% | -61.6% | -88.8% | -26.9% | 831.3% | 7.1% |
Europe | | | | | -72.3% | 18.0% | -7.2% | -20.1% |
Asia | | | | -3.8% | 182.3% | 62.5% | -39.8% | 76.8% |
Australia | | | | | 431.5% | 810.4% | -19.5% | -16.3% |
Cost of goods sold | 23.1 | 31.2 | 20.7 | 65.8 | 86.1 | 79.1 | 74.7 | 79.3 |
Gross profit | -10.3 | -19.9 | 1.3 | 15.4 | 20.4 | 13.5 | 15.3 | 19.4 |
Gross margin | -80.5% | -175.3% | 5.9% | 18.9% | 19.2% | 14.6% | 17.0% | 19.6% |
Selling, general and administrative [+] | 9.5 | 6.4 | 7.1 | 10.5 | 13.6 | 14.3 | 10.6 | 13.3 |
Sales and marketing | 3.8 | 1.7 | 1.6 | 4.0 | 4.1 | 5.3 | 4.6 | 5.5 |
General and administrative | 5.7 | 4.7 | 5.5 | 6.6 | 9.5 | 9.0 | 6.0 | 7.8 |
Other selling, general and administrative | | | | | | | | |
EBITDA [+] | -19.7 | -26.2 | -5.3 | 4.9 | 8.3 | -0.2 | 5.1 | 7.8 |
EBITDA growth | -24.9% | 396.5% | -208.6% | -41.6% | -5211.6% | -103.2% | -34.0% | 5.0% |
EBITDA margin | -153.8% | -231.2% | -24.0% | 6.0% | 7.8% | -0.2% | 5.7% | 7.9% |
Depreciation | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 |
EBITA | -19.8 | -26.3 | -5.3 | 4.8 | 8.3 | -0.2 | 5.1 | 6.6 |
EBITA margin | -154.5% | -231.8% | -24.2% | 5.9% | 7.8% | -0.2% | 5.7% | 6.7% |
Amortization of intangibles | | | 0.5 | | 1.5 | 0.6 | 0.5 | 0.5 |
EBIT [+] | -19.8 | -26.3 | -5.8 | 4.8 | 6.8 | -0.8 | 4.6 | 6.1 |
EBIT growth | -24.7% | 353.8% | -220.1% | -29.1% | -988.1% | -116.5% | -24.0% | -0.1% |
EBIT margin | -154.5% | -231.8% | -26.4% | 5.9% | 6.4% | -0.8% | 5.1% | 6.2% |
Non-recurring items [+] | | | | | | | | 0.8 |
Asset impairment | | | | | | | | 0.8 |
Loss (gain) on sale of assets | | | | | | | | 0.0 |
Interest expense, net [+] | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 |
Interest expense | 0.0 | | | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 |
Interest income | | 0.0 | 0.0 | | | | | |
Other income (expense), net [+] | 0.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.8 | 4.4 |
Amortization of financing costs and debt discount | | | -0.2 | -0.1 | -0.1 | -0.1 | -0.1 | |
Gain (loss) on derivative instruments | | | | | | | -0.8 | 4.2 |
Gain (loss) on foreign currency transactions | 0.1 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other non-operating income | | | | | 0.0 | | | |
Other | 0.1 | 0.4 | 0.0 | 0.0 | -0.3 | -0.4 | -1.1 | 4.3 |
Pre-tax income | -19.8 | -26.4 | -5.9 | 4.5 | 6.5 | -1.1 | 3.6 | 9.5 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 2.8 | -0.8 | 0.2 | 1.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 42.3% | 74.1% | 4.5% | 10.3% |
Net income | -20.0 | -26.1 | -8.6 | 5.3 | 3.8 | -1.1 | 2.2 | 8.6 |
Net margin | -155.8% | -229.8% | -39.1% | 6.5% | 3.5% | -1.2% | 2.4% | 8.7% |
|
Basic EPS [+] | ($3.27) | ($4.49) | ($1.08) | $0.93 | $0.14 | ($0.01) | $0.15 | $0.42 |
Growth | -27.0% | 314.2% | -216.9% | 580.9% | -1284.5% | -107.7% | -64.5% | 62.8% |
Diluted EPS [+] | ($3.27) | ($4.49) | ($1.08) | $0.92 | $0.14 | ($0.01) | $0.15 | $0.42 |
Growth | -27.0% | 314.2% | -217.8% | 577.6% | -1281.2% | -107.7% | -64.3% | 64.2% |
|
|
Shares outstanding (basic) [+] | 6.1 | 5.7 | 5.7 | 5.7 | 27.7 | 25.4 | 22.8 | 20.4 |
Growth | 6.2% | 1.3% | -0.2% | -79.5% | 8.8% | 11.4% | 12.0% | 8.0% |
Shares outstanding (diluted) [+] | 6.1 | 5.7 | 5.7 | 5.7 | 27.8 | 25.4 | 22.8 | 20.5 |
Growth | 6.2% | 1.3% | -1.0% | -79.4% | 9.1% | 11.4% | 11.5% | 7.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |